The study evaluated multiple RNA‐based NGS panels for the identification of NTRK fusions, including TPM3‐NTRK1, in various cancer samples, including lung adenocarcinoma and papillary thyroid carcinoma (PTC). Here, TPM3 is linked to differentiated thyroid carcinoma.